These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7197717)

  • 1. Apomorphine: bioavailability and effect on stereotyped cage climbing in mice.
    Smith RV; Klein AE; Wilcox RE; Riffee WH
    J Pharm Sci; 1981 Oct; 70(10):1144-7. PubMed ID: 7197717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bioavailability of apomorphine in the rat with a portacaval venous anastomosis.
    Campbell A; Kula NS; Jeppsson B; Baldessarini RJ
    Eur J Pharmacol; 1980 Oct; 67(1):139-42. PubMed ID: 7191371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appearance of a stereotyped apomorphine-induced climbing in unresponsive DBA2 mice after subchronic manipulations of brain dopamine transmission.
    Duterte-Boucher D; Costentin J
    Psychopharmacology (Berl); 1989; 98(1):56-60. PubMed ID: 2543019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of apomorphine following intravenous, intraperitoneal and oral administration to mice and rats.
    Smith RV; Wilcox RE; Soine WH; Riffee WH; Baldessarini RJ; Kula NS
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):483-99. PubMed ID: 582213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects and cerebral pharmacokinetics of apomorphine in the rat: dependence upon the route of administration.
    Melzacka M; Wiszniowska G; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(4):309-17. PubMed ID: 574957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of multiple dopamine receptors in apomorphine and N-n-propylnorapomorphine-induced climbing and hypothermia.
    Moore NA; Axton MS
    Eur J Pharmacol; 1990 Mar; 178(2):195-201. PubMed ID: 2184043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the intracerebral injection technique to elucidate mechanisms of apomorphine climbing and its antagonism in the mouse.
    Costall B; Naylor RJ; Nohria V
    Psychopharmacology (Berl); 1981; 73(1):91-4. PubMed ID: 6785798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural manifestations elicited by apomorphine, influence of the route of administration.
    Barros HM; Braz S; Carlini EA
    Pharmacology; 1989; 38(5):335-40. PubMed ID: 2762376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of sensitivity to ambulation-increasing effect of apomorphine induced by repeated administration in mice.
    Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1984 Sep; 4(2):181-90. PubMed ID: 6543079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotypic and hypothermic effects of apomorphine and N-n-propylnorapomorphine in mice.
    Riffee WH; Wilcox RE; Smith RV
    Eur J Pharmacol; 1979 Mar; 54(3):273-7. PubMed ID: 570924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of apomorphine-induced cage climbing behaviour and methamphetamine stereotypy by fenfluramine in mice.
    Gada VP; Joshi VV; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1984; 28(4):326-30. PubMed ID: 6543532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of apomorphine in rat brain areas: relationship to stereotypy.
    Bianchi G; Landi M; Garattini S
    Eur J Pharmacol; 1986 Nov; 131(2-3):229-36. PubMed ID: 3816953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticipatory responding, exclusive drug-context pairing and conditioned effects in sensitization to apomorphine-induced climbing in mice.
    Tirelli E; Heidbreder CA
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Apr; 23(3):505-18. PubMed ID: 10378233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metoclopramide pretreatment on apomorphine induced cage climbing behaviour.
    Uppal RP
    Indian J Exp Biol; 1984 Apr; 22(4):224-5. PubMed ID: 6541194
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral facilitation following chronic administration of N-n-propylnorapomorphine.
    Wilcox RE; Riffee WH; Chen PC; Hammett S; Smith RV
    Psychopharmacology (Berl); 1980; 72(1):113-5. PubMed ID: 6781003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Snout contact fixation, climbing and gnawing during apomorphine stereotypy in rats from two substrains.
    Szechtman H; Ornstein K; Teitelbaum P; Golani I
    Eur J Pharmacol; 1982 Jun; 80(4):385-92. PubMed ID: 7201932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apocodeine-induced stereotypies and penile erection in rats.
    Baraldi M; Benassi-Benelli A; Bernabei MT; Cameroni R; Ferrari F; Ferrari P
    Neuropharmacology; 1979 Feb; 18(2):165-9. PubMed ID: 571052
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurotensin selectively antagonizes apomorphine-induced stereotyped climbing.
    Jolicoeur FB; Gagne MA; Rivest R; Drumheller A; St-Pierre S
    Pharmacol Biochem Behav; 1991 Feb; 38(2):463-5. PubMed ID: 2057514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological basis for N-n-propylnorapomorphine induced stereotypic cage climbing and behavioral arousal in mice.
    Wilcox RE; Riffee WH; Smith RV
    Pharmacol Biochem Behav; 1979 Dec; 11(6):653-9. PubMed ID: 43980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.